Target Price | $4.08 |
Price | $0.48 |
Potential |
750.00%
register free of charge
|
Number of Estimates | 3 |
3 Analysts have issued a price target Biotricity Inc 2026 .
The average Biotricity Inc target price is $4.08.
This is
750.00%
register free of charge
$4.20
775.00%
register free of charge
$4.04
741.67%
register free of charge
|
|
A rating was issued by 6 analysts: 0 Analysts recommend Biotricity Inc to buy, 3 to hold and 3 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Biotricity Inc stock has an average upside potential 2026 of
750.00%
register free of charge
|
Mar '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 12.06 | 13.97 |
25.10% | 15.87% | |
Net Margin | -123.80% | -103.98% |
38.89% | 16.01% |
3 Analysts have issued a sales forecast Biotricity Inc 2025 . The average Biotricity Inc sales estimate is
This results in the following potential growth metrics:
3 Biotricity Inc Analysts have issued a net profit forecast 2025. The average Biotricity Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Mar '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.66 | -0.59 |
26.55% | 64.46% | |
P/E | negative | |
EV/Sales | 2.63 |
3 Analysts have issued a Biotricity Inc forecast for earnings per share. The average Biotricity Inc EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 18 2024 |
Analyst Rating | Date |
---|---|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 18 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.